Cargando…
Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients
BACKGROUND: The B-cell translocation gene 2 (BTG2) is considered to act as a tumour-suppressor gene because of its antiproliferative and antimigratory activities. Higher levels of BTG2 expression in tumour cells have been linked to a better clinical outcome for several cancer entities. Here, we inve...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590653/ https://www.ncbi.nlm.nih.gov/pubmed/23299537 http://dx.doi.org/10.1038/bjc.2012.573 |
_version_ | 1782261901404667904 |
---|---|
author | Wagener, N Bulkescher, J Macher-Goeppinger, S Karapanagiotou-Schenkel, I Hatiboglu, G Abdel-Rahim, M Abol- Enein, H Ghoneim, M A Bastian, P J Müller, S C Haferkamp, A Hohenfellner, M Hoppe-Seyler, F Hoppe-Seyler, K |
author_facet | Wagener, N Bulkescher, J Macher-Goeppinger, S Karapanagiotou-Schenkel, I Hatiboglu, G Abdel-Rahim, M Abol- Enein, H Ghoneim, M A Bastian, P J Müller, S C Haferkamp, A Hohenfellner, M Hoppe-Seyler, F Hoppe-Seyler, K |
author_sort | Wagener, N |
collection | PubMed |
description | BACKGROUND: The B-cell translocation gene 2 (BTG2) is considered to act as a tumour-suppressor gene because of its antiproliferative and antimigratory activities. Higher levels of BTG2 expression in tumour cells have been linked to a better clinical outcome for several cancer entities. Here, we investigated the expression and function of BTG2 in bladder cancer. METHODS: The expression of BTG2 in bladder cancer cells was silenced by RNA interference. Cell motility was investigated by wound healing and Boyden chamber assays. The protein expression of BTG2 in bladder cancer was studied by immunohistochemistry. RESULTS: We observed that targeted suppression of BTG2 by RNA interference did not result in growth stimulation but led to a substantial inhibition of bladder cancer cell motility. Tissue microarray analyses of bladder cancer cystectomy specimens revealed that higher BTG2 expression levels within the tumours correlated strongly with a decreased cancer-specific survival for bladder cancer patients. CONCLUSION: These results indicate that endogenous BTG2 expression contributes to the migratory potential of bladder cancer cells. Moreover, high levels of BTG2 in bladder cancers are linked to decreased cancer-specific survival. These findings question the conception that BTG2 generally acts as a tumour suppressor and typically represents a favourable clinical marker for cancer patients. |
format | Online Article Text |
id | pubmed-3590653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-35906532014-03-05 Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients Wagener, N Bulkescher, J Macher-Goeppinger, S Karapanagiotou-Schenkel, I Hatiboglu, G Abdel-Rahim, M Abol- Enein, H Ghoneim, M A Bastian, P J Müller, S C Haferkamp, A Hohenfellner, M Hoppe-Seyler, F Hoppe-Seyler, K Br J Cancer Genetics and Genomics BACKGROUND: The B-cell translocation gene 2 (BTG2) is considered to act as a tumour-suppressor gene because of its antiproliferative and antimigratory activities. Higher levels of BTG2 expression in tumour cells have been linked to a better clinical outcome for several cancer entities. Here, we investigated the expression and function of BTG2 in bladder cancer. METHODS: The expression of BTG2 in bladder cancer cells was silenced by RNA interference. Cell motility was investigated by wound healing and Boyden chamber assays. The protein expression of BTG2 in bladder cancer was studied by immunohistochemistry. RESULTS: We observed that targeted suppression of BTG2 by RNA interference did not result in growth stimulation but led to a substantial inhibition of bladder cancer cell motility. Tissue microarray analyses of bladder cancer cystectomy specimens revealed that higher BTG2 expression levels within the tumours correlated strongly with a decreased cancer-specific survival for bladder cancer patients. CONCLUSION: These results indicate that endogenous BTG2 expression contributes to the migratory potential of bladder cancer cells. Moreover, high levels of BTG2 in bladder cancers are linked to decreased cancer-specific survival. These findings question the conception that BTG2 generally acts as a tumour suppressor and typically represents a favourable clinical marker for cancer patients. Nature Publishing Group 2013-03-05 2013-01-08 /pmc/articles/PMC3590653/ /pubmed/23299537 http://dx.doi.org/10.1038/bjc.2012.573 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Genetics and Genomics Wagener, N Bulkescher, J Macher-Goeppinger, S Karapanagiotou-Schenkel, I Hatiboglu, G Abdel-Rahim, M Abol- Enein, H Ghoneim, M A Bastian, P J Müller, S C Haferkamp, A Hohenfellner, M Hoppe-Seyler, F Hoppe-Seyler, K Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients |
title | Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients |
title_full | Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients |
title_fullStr | Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients |
title_full_unstemmed | Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients |
title_short | Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients |
title_sort | endogenous btg2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients |
topic | Genetics and Genomics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590653/ https://www.ncbi.nlm.nih.gov/pubmed/23299537 http://dx.doi.org/10.1038/bjc.2012.573 |
work_keys_str_mv | AT wagenern endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT bulkescherj endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT machergoeppingers endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT karapanagiotouschenkeli endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT hatiboglug endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT abdelrahimm endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT aboleneinh endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT ghoneimma endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT bastianpj endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT mullersc endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT haferkampa endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT hohenfellnerm endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT hoppeseylerf endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients AT hoppeseylerk endogenousbtg2expressionstimulatesmigrationofbladdercancercellsandcorrelateswithpoorclinicalprognosisforbladdercancerpatients |